Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001731122-22-001145
Filing Date
2022-06-29
Accepted
2022-06-29 17:12:13
Documents
1
Period of Report
2022-06-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3691
  Complete submission text file 0001731122-22-001145.txt   5153
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address REGINA-KIRCHMAIER STRASSE 4 KAUFBEUREN 2M 87600
Business Address
Donhauser Peter D.O. (Reporting) CIK: 0001698234 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37606 | Film No.: 221055478